Branched-chain α-keto acid metabolism is controlled by SLC25A35-mediated mitochondrial import

Liver is considered a primary site for systemic branched-chain alpha-keto acid (BCKA) oxidation due to its abundant dehydrogenase content. However, hepatocytes rely entirely on import of substrate generated elsewhere because they lack intrinsic branched-chain transaminase activity. The mechanisms governing BCKA transit into the mitochondrial matrix remain unknown. We found that mitochondrial import, rather than dehydrogenase activity, determines hepatocellular capacity for BCKA oxidation. We identified MCT1 and MCT2 as transporters required for cellular entry and SLC25A35 as the essential mitochondrial BCKA carrier. Crucially, hepatic SLC25A35 expression is low and limits the liver's contribution to systemic clearance. These findings establish the molecular machinery for BCKA transport and redefine the liver's role in BCKA homeostasis, revealing that mitochondrial transporter abundance, rather than dehydrogenase levels, dictates BCKA metabolic flux.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-18
DOI
https://doi.org/10.64898/2026.11.14.766690
Primary Topic
Metabolism and Genetic Disorders
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Branched-chain α-keto acid metabolism is controlled by SLC25A35-mediated mitochondrial import

Robert W. McGarrah, Phillip James White, Jacquelyn M. Walejko, Olga Ilkayeva et al.
bioRxiv (Cold Spring Harbor Laboratory)
Metabolism and Genetic Disorders
preprint

Branched-chain α-keto acid metabolism is controlled by SLC25A35-mediated mitochondrial import

Robert W. McGarrah, Phillip James White, Jacquelyn M. Walejko, Olga Ilkayeva, Matthew W. Foster, Yann Deleye, Zachary Gerhart‐Hines, Neha Majety, Wentao He, Esra Akkaya, Guo-Fang Zhang, Sreya Varanasi, Sean Ferrano, Iuliaa Karavaeva
preprint en

Abstract

Liver is considered a primary site for systemic branched-chain alpha-keto acid (BCKA) oxidation due to its abundant dehydrogenase content. However, hepatocytes rely entirely on import of substrate generated elsewhere because they lack intrinsic branched-chain transaminase activity. The mechanisms governing BCKA transit into the mitochondrial matrix remain unknown. We found that mitochondrial import, rather than dehydrogenase activity, determines hepatocellular capacity for BCKA oxidation. We identified MCT1 and MCT2 as transporters required for cellular entry and SLC25A35 as the essential mitochondrial BCKA carrier. Crucially, hepatic SLC25A35 expression is low and limits the liver's contribution to systemic clearance. These findings establish the molecular machinery for BCKA transport and redefine the liver's role in BCKA homeostasis, revealing that mitochondrial transporter abundance, rather than dehydrogenase levels, dictates BCKA metabolic flux.

bioRxiv (Cold Spring Harbor Laboratory)
University of Copenhagen (DK), Duke University (US), Abterra Biosciences (United States) (US), Duke Medical Center (US), Novo Nordisk Foundation Center for Basic Metabolic Research (DK)
Metabolism and Genetic Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon